Gary Gershony, Director of Cardiovascular Research, Education and Technology at John Muir Health episode artwork

EPISODE · Sep 9, 2020 · 42 MIN

Gary Gershony, Director of Cardiovascular Research, Education and Technology at John Muir Health

from Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere · host Julio G. Martinez-Clark

Dr. Gershony was the Founder of Vascular Solutions, Inc. (Minneapolis, MN), which had a successful IPO in 2000, and for which he served as Chief Medical Officer and a member of the Board of Directors from 1996-2002. Dr. Gershony was the principal inventor of the DuettTM Vascular Sealing Device manufactured by Vascular Solutions. Dr. Gershony was also the Co-Founder and Chief Medical Officer of AngioScore, Inc. (Fremont, CA), a medical device company devoted to developing unique angioplasty scoring balloon catheters to address a variety of important clinical needs during coronary and peripheral interventional procedures. He was a member of the senior management team from 2003 until AngioScore’s successful acquisition in 2014. Dr. Gershony has served on the adjunct faculty of the Stanford Biodesign Innovation Program. He also completed an Executive Program in finance and accounting (FANFE) at the Stanford Graduate School of Business in 2007. Dr. Gershony is the author of 10 issued medical device patents. He has been a member of the scientific advisory board or a consultant to numerous medical device companies and venture capitalists in the Bay Area and elsewhere. Dr. Gershony is an active early-stage MedTech company investor and mentor, a member of Life Science Angels Medical Device and Digital Health Committee, and a member of the Band of Angels. 

Episode metadata supplied by the publisher feed · Published Sep 9, 2020

Embed this episode

Dr. Gershony was the Founder of Vascular Solutions, Inc. (Minneapolis, MN), which had a successful IPO in 2000, and for which he served as Chief Medical Officer and a member of the Board of Directors from 1996-2002. Dr. Gershony was the principal inventor of the DuettTM Vascular Sealing Device manufactured by Vascular Solutions. Dr. Gershony was also the Co-Founder and Chief Medical Officer of AngioScore, Inc. (Fremont, CA), a medical device company devoted to developing unique angioplasty sc...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Gary Gershony, Director of Cardiovascular Research, Education and Technology at John Muir Health

0:00 42:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere?

This episode is 42 minutes long.

When was this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode published?

This episode was published on September 9, 2020.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!